Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma

Lung Cancer Histologic and Immunohistochemical Heterogeneity in the Era of Molecular Therapies

(2014) Annamaria Cadioli et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma

(2014) Yang Zhang et al.   Scientific Reports

Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma

(2014) Kenichi Suda et al.   Biomed Research International

Intratumor heterogeneity: Nature and biological significance

(2013) T. S. Gerashchenko et al.   BIOCHEMISTRY-MOSCOW

Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma

(2013) Nanae Tomonaga et al.   Clinical Lung Cancer

Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?

(2013) Renato Franco et al.   Expert Review of Anticancer Therapy

ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma

(2012) Jamie E. Chaft et al.   Journal of Thoracic Oncology

EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas

(2012) Z.-Y. Chen et al.   ONCOLOGIST

Histopathologic Characteristics of Lung Adenocarcinomas With Epidermal Growth Factor Receptor Mutations in the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification

(2011) Hyo Sup Shim et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer

(2011) Jan Nyrop Jakobsen et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Heterogeneous Distribution of EGFR Mutations Is Extremely Rare in Lung Adenocarcinoma

(2011) Yasushi Yatabe et al.   JOURNAL OF CLINICAL ONCOLOGY

Lung Adenocarcinoma with Concurrent Exon 19 EGFR Mutation and ALK Rearrangement Responding to Erlotinib

(2011) Sanjay Popat et al.   Journal of Thoracic Oncology

Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH

(2011) Eunhee S. Yi et al.   Journal of Thoracic Oncology

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

(2010) Gabriel Sica et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment

(2010) D. R. Camidge et al.   CLINICAL CANCER RESEARCH

Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR

(2010) Marie Brevet et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies

(2010) Eran R. Andrechek et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations

(2010) M. Tiseo et al.   LUNG CANCER

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

(2010) Xuchao Zhang et al.   Molecular Cancer

TheEML4-ALKfusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-typeEGFRandKRAS

(2009) Daisy Wing-Sze Wong et al.   CANCER

Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

(2009) S. J. Rodig et al.   CLINICAL CANCER RESEARCH

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology and young onset

(2009) Kentaro Inamura et al.   MODERN PATHOLOGY

Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis

(2008) Noriko Motoi et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Epidermal Growth Factor Receptor Gene Amplification Is Acquired in Association with Tumor Progression of EGFR-Mutated Lung Cancer

(2008) Y. Yatabe et al.   CANCER RESEARCH

Induction of lung adenocarcinoma in transgenic mice expressing activatedEGFRdriven by the SP-C promoter

(2008) Kadoaki Ohashi et al.   CANCER SCIENCE

Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung

(2008) Junichi Soh et al.   Journal of Thoracic Oncology

EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers

(2008) Kentaro Inamura et al.   Journal of Thoracic Oncology